 |
Radionetics Oncology
Last updated: August 02, 2024
CEO - Paul Grayson
USA | Funding: $135M (+)
Website: https://radionetics.com
Radionetics Oncology is a pharmaceutical company that focuses on the discovery and development of novel radiotherapeutics.
Website: https://radionetics.com
Radionetics Oncology is a pharmaceutical company that focuses on the discovery and development of novel radiotherapeutics.
